Else Nutrition Holdings Inc. (BABYD) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Else Nutrition Holdings Inc. (BABYD) trades at $0.0942 with AI Score 42/100 (Grade C). Else Nutrition Holdings Inc. focuses on developing and selling plant-based food and nutrition products for infants, toddlers, children, and adults. Sector: Consumer defensive.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for BABYD: BABYD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BABYD against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BABYD: 2/3 scored disciplines lean bearish. Dominant signal: Jim Simons bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Else Nutrition Holdings Inc. (BABYD) Consumer Business Overview
Else Nutrition Holdings Inc. develops, produces, and sells plant-based nutritional products targeting infants, toddlers, children, and adults in North America and Israel. With a focus on online sales, the company competes in the packaged foods sector, offering alternatives to traditional dairy-based products.
What Is the Investment Thesis for BABYD?
Investing in Else Nutrition Holdings Inc. (BABYD) presents a high-risk, high-reward opportunity. The company's focus on plant-based nutrition caters to a growing market segment, but its negative profit margin of -149.2% and gross margin of -32.4% indicate significant challenges. The company's beta of 1.18 suggests higher volatility compared to the market. Growth catalysts include expanding distribution channels and increasing brand awareness in North America and Israel. However, the company's reliance on online sales and the competitive landscape of the packaged foods industry pose risks. Investors should closely monitor Else Nutrition's ability to improve its financial performance and achieve profitability.
Based on FMP financials and quantitative analysis
BABYD Key Highlights
Else Nutrition operates in the Consumer Defensive sector, specifically the Packaged Foods industry.
- The company's market capitalization is $0.00B, indicating its small size within the market.
- Else Nutrition's P/E ratio is -0.26, reflecting its current lack of profitability.
- The company's profit margin is -149.2%, highlighting significant financial challenges.
- Else Nutrition's gross margin is -32.4%, indicating that the cost of goods sold exceeds revenue.
Who Are BABYD's Competitors?
BABYD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BRCNF Burcon NutraScience Corporation | $1.35 | -2.88% | $17.1M | 59 |
| JVA Coffee Holding Co., Inc. | $3.52 | +0.57% | $20.1M | 74 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $2.02 | +0.00% | $35.8M | 64 |
| BUBSF Bubs Australia Limited | $0.08 | +0.00% | $69.2M | 53 |
| LFVN LifeVantage Corporation | $6.58 | +1.31% | $83.1M | 77 |
| FTLF FitLife Brands, Inc. | $10.01 | -2.20% | $94.0M | 59 |
| HBFGF Happy Belly Food Group Inc. | $1.23 | +3.58% | $182M | 57 |
| USNA USANA Health Sciences, Inc. | $13.18 | -0.53% | $243M | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BABYD's Key Strengths?
Focus on plant-based nutrition aligns with growing consumer trends.
- Proprietary formulations for plant-based baby formula.
- Direct-to-consumer online sales channel.
- Presence in North America and Israel.
What Are BABYD's Weaknesses?
Negative profit margin and gross margin.
- Limited brand recognition compared to established competitors.
- Reliance on online sales channel.
- Small market capitalization.
What Could Drive BABYD Stock Higher?
Expansion of product distribution channels in North America and Israel.
- Potential partnerships with major retailers to increase shelf space.
- Launch of new plant-based nutrition products targeting specific age groups.
- Increased marketing efforts to raise brand awareness and drive online sales.
What Are the Key Risks for BABYD?
Financial-distress signal — its Altman Z-Score of -33.42 sits in the distress zone (elevated bankruptcy risk).
- Competition from established players in the infant formula and nutrition segments.
- Fluctuations in consumer preferences and demand for plant-based products.
- Regulatory changes in the food industry affecting product labeling and marketing.
- Negative profit margin and gross margin impacting financial sustainability.
- Limited liquidity and trading volume on the OTC market.
What Are the Growth Opportunities for BABYD?
- Expansion into New Geographies: Else Nutrition has the opportunity to expand its geographic reach beyond North America and Israel. Entering new markets in Europe and Asia, where there is growing demand for plant-based products, could significantly increase the company's revenue. This expansion could be achieved through partnerships with local distributors or by establishing a direct online presence. The timeline for this expansion is estimated to be within the next 3-5 years.
- Product Line Expansion: Else Nutrition can expand its product line to include a wider range of plant-based nutrition products. This could include developing new formulas for different age groups, as well as introducing new snack and meal options. By diversifying its product offerings, Else Nutrition can attract a broader customer base and increase its revenue per customer. The timeline for this expansion is estimated to be within the next 2-3 years.
- Strategic Partnerships: Forming strategic partnerships with retailers, healthcare providers, and other organizations can help Else Nutrition increase its brand awareness and distribution reach. Collaborating with major retailers to secure shelf space in their stores can significantly boost sales. Partnering with healthcare providers to promote the benefits of plant-based nutrition can enhance the company's credibility. The timeline for establishing these partnerships is estimated to be within the next 1-2 years.
- Enhanced Online Presence: Else Nutrition can further enhance its online presence through targeted marketing campaigns and improved e-commerce functionality. Investing in search engine optimization (SEO) and social media marketing can help the company attract more online customers. Improving the user experience on its website and offering personalized recommendations can increase conversion rates. The timeline for enhancing its online presence is estimated to be within the next 6-12 months.
- Focus on Sustainability: Else Nutrition can further emphasize its commitment to sustainability to attract environmentally conscious consumers. Highlighting the environmental benefits of plant-based nutrition and implementing sustainable packaging practices can enhance the company's brand image. Communicating its sustainability initiatives through marketing campaigns and public relations efforts can resonate with consumers who prioritize environmental responsibility. The timeline for implementing these sustainability initiatives is estimated to be ongoing.
What Are BABYD's Competitive Advantages?
- Focus on plant-based nutrition differentiates it from traditional dairy-based competitors.
- Proprietary formulations for plant-based baby formula.
- Direct-to-consumer online sales channel provides control over distribution and customer relationships.
What Does BABYD Do?
Else Nutrition Holdings Inc. is an Israel-based food and nutrition company focused on developing plant-based alternatives to traditional dairy-based formulas and products. Founded with the mission of providing healthier and more sustainable nutrition options, Else Nutrition caters to infants, toddlers, children, and adults. The company's product line includes plant-based baby formula, toddler nutrition products, children's snacks, and adult nutrition shakes. These products are designed to offer complete and balanced nutrition using plant-based ingredients. Else Nutrition distributes its products primarily in North America and Israel, leveraging online channels to reach a broad customer base. The company's commitment to innovation and sustainability positions it as a player in the evolving landscape of the packaged foods industry, particularly within the infant and child nutrition segments. Else Nutrition aims to address the growing demand for plant-based options and cater to consumers seeking alternatives to traditional dairy-based products. The company's headquarters are located in Tel Aviv-Yafo, Israel, reflecting its origins and continued focus on innovation in the food technology sector.
What Products and Services Does BABYD Offer?
- Develops plant-based food and nutrition products.
- Produces baby snacks and feeding accessories.
- Offers plant-based baby formula products.
- Creates toddler and children nutrition products.
- Provides adult nutrition products.
- Sells products online in North America and Israel.
How Does BABYD Make Money?
- Develops and manufactures plant-based nutrition products.
- Sells products directly to consumers through online channels.
- Generates revenue through the sale of baby formula, snacks, and nutrition products.
What Industry Does BABYD Operate In?
Else Nutrition operates within the competitive packaged foods industry, which is experiencing a shift towards healthier and plant-based alternatives. Else Nutrition competes with established players in the infant formula and nutrition segments, as well as emerging plant-based brands. The company's success depends on its ability to differentiate its products, build brand recognition, and establish strong distribution channels. Competitors include AMNC, CMGHF, CULTF, CYAN, and HRSR.
Who Are BABYD's Key Customers?
- Infants and toddlers requiring formula.
- Parents seeking plant-based nutrition options for their children.
- Adults looking for plant-based nutrition supplements.
Company Profile
Else Nutrition Holdings Inc. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Tel Aviv, IL. The company is led by CEO Hamutal Yitzhak. BABYD has traded publicly since 2019.
Else Nutrition Holdings Inc. Financial Trajectory
Else Nutrition Holdings Inc. (BABYD) reported $1.7M in revenue for Q3 2025, reflecting 10.9% growth compared to the prior quarter. The company recorded a net loss of $602K, with diluted EPS of $-0.02. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Consumer Defensive. Across the four most recent quarters, BABYD averaged $-0.02 in diluted EPS.
How Else Nutrition Holdings Inc. Is Valued
Relative to its peer group, BABYD's quantitative score of 42/100 is below the peer average of 65/100.
Key Financial Metrics
Return on equity for Else Nutrition Holdings Inc. stands at 228.3%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.39 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Else Nutrition Holdings Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -33.42 places it in the distress zone, a signal of elevated financial risk.
BABYD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Else Nutrition's long-term prospects, signaling potential undervaluation.
- The community is buzzing about new product launches and positive consumer feedback, indicating growing brand recognition.
- Else Nutrition's focus on plant-based nutrition aligns with increasing consumer demand for healthier alternatives.
- Positive sentiment around the company's expansion into new markets fuels optimism about future revenue growth.
Bear Case
- Limited brand awareness compared to established players in the baby food market poses a significant challenge.
- Community concerns exist regarding the company's ability to scale production to meet growing demand.
- Negative market perception stems from recent supply chain disruptions affecting product availability.
- Bearish community views highlight the competitive landscape and potential pricing pressures impacting margins.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $2M | -$602,000 | -$0.02 |
| Q2 2025 | $2M | -$1M | -$0.0047 |
| Q1 2025 | $2M | -$3M | -$0.01 |
| Q4 2024 | $1M | -$4M | -$0.03 |
Based on FMP financials and quantitative analysis
BABYD Latest News
No recent news available for BABYD.
BABYD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BABYD.
Price Targets
Wall Street price target analysis for BABYD.
BABYD MoonshotScore
What does this score mean?
The MoonshotScore rates BABYD 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Hamutal Yitzhak
CEO
Hamutal Yitzhak serves as the CEO of Else Nutrition Holdings Inc. Her background includes experience in the food and nutrition industry, with a focus on developing innovative products and expanding market reach. She has a proven track record of leading teams and driving growth in the consumer goods sector. Her expertise lies in strategic planning, product development, and marketing. She is responsible for overseeing the company's operations and executing its growth strategy.
Track Record: Under Hamutal Yitzhak's leadership, Else Nutrition has focused on expanding its product line and increasing its online presence. She has overseen the launch of new plant-based nutrition products and the implementation of targeted marketing campaigns. Her strategic decisions have contributed to the company's growth in North America and Israel. She continues to drive innovation and sustainability within the organization.
BABYD OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Else Nutrition Holdings Inc. may not meet the minimum financial or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, and trading activity can be sporadic. Investing in companies on the OTC Other tier carries higher risk due to the potential for limited information and liquidity compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Lower trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight compared to major exchanges.
- Verify the company's financial statements and reporting practices.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Monitor trading activity and price volatility.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Company's presence in the plant-based nutrition market.
- Development of proprietary plant-based formulas.
- Online sales channel and direct-to-consumer approach.
- Operations in North America and Israel.
- CEO with experience in the food and nutrition industry.
BABYD Consumer Defensive Stock FAQ
What does the AI Score mean for BABYD?
BABYD holds an AI Score of 42/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Else Nutrition Holdings Inc. focuses on developing and selling plant-based food and nutrition products for infants, toddlers, children, and adults. The company operates primarily in North America …
What does Else Nutrition Holdings Inc. do?
Else Nutrition Holdings Inc. specializes in the development, production, and sale of plant-based food and nutrition products. Their primary focus is on providing alternatives to traditional dairy-based formulas for infants, toddlers, children, and adults. The company offers a range of products, including baby snacks, feeding accessories, plant-based baby formula, and nutrition products for various age groups.
What are the main risks for BABYD?
The main risks for Else Nutrition Holdings Inc. include intense competition from established players in the packaged foods and infant formula industries, the company's current lack of profitability as evidenced by its negative profit and gross margins, and the inherent risks associated with trading on the OTC market, such as limited liquidity and regulatory oversight.
What are the key factors to evaluate for BABYD?
Else Nutrition Holdings Inc. (BABYD) holds an AI score of 42/100 (low). Investing in Else Nutrition Holdings Inc. Not financial advice.
How frequently does BABYD data refresh on this page?
BABYD's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BABYD's recent stock price performance?
Else Nutrition Holdings Inc. (BABYD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on plant-based nutrition aligns with growing consumer trends. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BABYD overvalued or undervalued right now?
Else Nutrition Holdings Inc. (BABYD) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research BABYD before investing?
Before investing in Else Nutrition Holdings Inc. (BABYD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding BABYD to a portfolio?
Key strength of Else Nutrition Holdings Inc. (BABYD): Focus on plant-based nutrition aligns with growing consumer trends. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited or inconsistent.
- AI analysis is pending for BABYD.